FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3187856265> ?p ?o ?g. }

• W3187856265 endingPage "1982" @default.
• W3187856265 startingPage "1977" @default.
• W3187856265 abstract "Postural tachycardia syndrome (POTS) is a common childhood disease that seriously affects the patient's physical and mental health. This study aimed to investigate whether pre-treatment baseline left ventricular ejection fraction (LVEF) and left ventricular fractional shortening (LVFS) values were associated with symptom improvement after metoprolol therapy for children and adolescents with POTS.This retrospective study evaluated 51 children and adolescents with POTS who received metoprolol therapy at the Peking University First Hospital between November 2010 and July 2019. All patients had completed a standing test or basic head-up tilt test and cardiac echocardiography before treatment. Treatment response was evaluated 3 months after starting metoprolol therapy. The pre-treatment baseline LVEF and LVFS values were evaluated for correlations with decreases in the symptom score after treatment (ΔSS). Multivariable analysis was performed using factors with a P value of <0.100 in the univariate analyses and the demographic characteristics.A comparison of responders and non-responders revealed no significant differences in demographic, hemodynamic characteristics, and urine specific gravity (all P > 0.050). However, responders had significantly higher baseline LVEF (71.09% ± 4.44% vs. 67.17% ± 4.88%, t = -2.789, P = 0.008) and LVFS values (40.00 [38.00, 42.00]% vs. 36.79% ± 4.11%, Z = -2.542, P = 0.010) than the non-responders. The baseline LVEF and LVFS were positively correlated with ΔSS (r = 0.378, P = 0.006; r = 0.363, P = 0.009), respectively. Logistic regression analysis revealed that LVEF was independently associated with the response to metoprolol therapy in children and adolescents with POTS (odds ratio: 1.201, 95% confidence interval: 1.039-1.387, P = 0.013).Pre-treatment baseline LVEF was associated with symptom improvement after metoprolol treatment for children and adolescents with POTS." @default.
• W3187856265 created "2021-08-16" @default.
• W3187856265 creator A5000401545 @default.
• W3187856265 creator A5008346473 @default.
• W3187856265 creator A5013939729 @default.
• W3187856265 creator A5026966223 @default.
• W3187856265 creator A5059474491 @default.
• W3187856265 creator A5061978481 @default.
• W3187856265 creator A5069516330 @default.
• W3187856265 creator A5075445076 @default.
• W3187856265 creator A5085140875 @default.
• W3187856265 creator A5087765551 @default.
• W3187856265 date "2021-08-12" @default.
• W3187856265 modified "2023-09-25" @default.
• W3187856265 title "Baseline left ventricular ejection fraction associated with symptom improvements in both children and adolescents with postural tachycardia syndrome under metoprolol therapy" @default.
• W3187856265 cites W1947878856 @default.
• W3187856265 cites W1964712692 @default.
• W3187856265 cites W1970581755 @default.
• W3187856265 cites W1972208458 @default.
• W3187856265 cites W1977162192 @default.
• W3187856265 cites W1997113432 @default.
• W3187856265 cites W2002273400 @default.
• W3187856265 cites W2025957772 @default.
• W3187856265 cites W2027270298 @default.
• W3187856265 cites W2034959806 @default.
• W3187856265 cites W2043589636 @default.
• W3187856265 cites W2045755315 @default.
• W3187856265 cites W2055368825 @default.
• W3187856265 cites W2057337222 @default.
• W3187856265 cites W2057908896 @default.
• W3187856265 cites W2073652489 @default.
• W3187856265 cites W2083267508 @default.
• W3187856265 cites W2113154196 @default.
• W3187856265 cites W2124150162 @default.
• W3187856265 cites W2125061297 @default.
• W3187856265 cites W2126774767 @default.
• W3187856265 cites W2133465432 @default.
• W3187856265 cites W2133700167 @default.
• W3187856265 cites W2140503782 @default.
• W3187856265 cites W2149406742 @default.
• W3187856265 cites W2470320473 @default.
• W3187856265 cites W2782849077 @default.
• W3187856265 cites W2803832030 @default.
• W3187856265 cites W2897300281 @default.
• W3187856265 cites W2909847296 @default.
• W3187856265 cites W2921285569 @default.
• W3187856265 cites W2938717438 @default.
• W3187856265 cites W2942819007 @default.
• W3187856265 cites W2975157746 @default.
• W3187856265 cites W2987159528 @default.
• W3187856265 cites W3143753128 @default.
• W3187856265 cites W3150093627 @default.
• W3187856265 cites W4242560816 @default.
• W3187856265 cites W97622595 @default.
• W3187856265 doi "https://doi.org/10.1097/cm9.0000000000001698" @default.
• W3187856265 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8382470" @default.
• W3187856265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34387611" @default.
• W3187856265 hasPublicationYear "2021" @default.
• W3187856265 type Work @default.
• W3187856265 sameAs 3187856265 @default.
• W3187856265 citedByCount "1" @default.
• W3187856265 countsByYear W31878562652022 @default.
• W3187856265 crossrefType "journal-article" @default.
• W3187856265 hasAuthorship W3187856265A5000401545 @default.
• W3187856265 hasAuthorship W3187856265A5008346473 @default.
• W3187856265 hasAuthorship W3187856265A5013939729 @default.
• W3187856265 hasAuthorship W3187856265A5026966223 @default.
• W3187856265 hasAuthorship W3187856265A5059474491 @default.
• W3187856265 hasAuthorship W3187856265A5061978481 @default.
• W3187856265 hasAuthorship W3187856265A5069516330 @default.
• W3187856265 hasAuthorship W3187856265A5075445076 @default.
• W3187856265 hasAuthorship W3187856265A5085140875 @default.
• W3187856265 hasAuthorship W3187856265A5087765551 @default.
• W3187856265 hasBestOaLocation W31878562651 @default.
• W3187856265 hasConcept C126322002 @default.
• W3187856265 hasConcept C144301174 @default.
• W3187856265 hasConcept C164705383 @default.
• W3187856265 hasConcept C2776331378 @default.
• W3187856265 hasConcept C2778198053 @default.
• W3187856265 hasConcept C2781280847 @default.
• W3187856265 hasConcept C38180746 @default.
• W3187856265 hasConcept C71924100 @default.
• W3187856265 hasConcept C78085059 @default.
• W3187856265 hasConcept C80461066 @default.
• W3187856265 hasConceptScore W3187856265C126322002 @default.
• W3187856265 hasConceptScore W3187856265C144301174 @default.
• W3187856265 hasConceptScore W3187856265C164705383 @default.
• W3187856265 hasConceptScore W3187856265C2776331378 @default.
• W3187856265 hasConceptScore W3187856265C2778198053 @default.
• W3187856265 hasConceptScore W3187856265C2781280847 @default.
• W3187856265 hasConceptScore W3187856265C38180746 @default.
• W3187856265 hasConceptScore W3187856265C71924100 @default.
• W3187856265 hasConceptScore W3187856265C78085059 @default.
• W3187856265 hasConceptScore W3187856265C80461066 @default.
• W3187856265 hasIssue "16" @default.
• W3187856265 hasLocation W31878562651 @default.
• W3187856265 hasLocation W31878562652 @default.
• W3187856265 hasLocation W31878562653 @default.

• next